These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 8892346

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Regional differences in apolipoprotein E immunoreactivity in diffuse plaques in Alzheimer's disease brain.
    Kida E, Golabek AA, Wisniewski T, Wisniewski KE.
    Neurosci Lett; 1994 Feb 14; 167(1-2):73-6. PubMed ID: 8177532
    [Abstract] [Full Text] [Related]

  • 4. Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's disease.
    Namba Y, Tsuchiya H, Ikeda K.
    Neurosci Lett; 1992 Jan 06; 134(2):264-6. PubMed ID: 1375354
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N, Fukatsu R, Tsuzuki K, Hayashi Y, Yoshida T, Fujii N, Koike T, Wakayama I, Yanagihara R, Garruto R, Amano N, Makita Z.
    Am J Pathol; 1998 Oct 06; 153(4):1149-55. PubMed ID: 9777946
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease.
    Perry G, Cras P, Siedlak SL, Tabaton M, Kawai M.
    Am J Pathol; 1992 Feb 06; 140(2):283-90. PubMed ID: 1739122
    [Abstract] [Full Text] [Related]

  • 11. Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease.
    Perry G, Richey PL, Siedlak SL, Smith MA, Mulvihill P, DeWitt DA, Barnett J, Greenberg BD, Kalaria RN.
    Am J Pathol; 1993 Dec 06; 143(6):1586-93. PubMed ID: 7504885
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
    Han SH, Hulette C, Saunders AM, Einstein G, Pericak-Vance M, Strittmatter WJ, Roses AD, Schmechel DE.
    Exp Neurol; 1994 Jul 06; 128(1):13-26. PubMed ID: 8070517
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.
    Schwab C, Hosokawa M, McGeer PL.
    Exp Neurol; 2004 Jul 06; 188(1):52-64. PubMed ID: 15191802
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease.
    Münch G, Cunningham AM, Riederer P, Braak E.
    Brain Res; 1998 Jun 15; 796(1-2):307-10. PubMed ID: 9689484
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.